In this study, the combination of serum MIC-1 with CA19-9 yielded a sensitivity of 82.6% (19/23) and a specificity of 72.4% (21/29), which are sufficiently high for screening biliary tract cancer. Here, GDF15 is linked to biliary tract cancer.